SUM102PT - Cell Line (ID:51120)
| HMS LINCS ID: | 51120 |
| Name: | SUM102PT |
| Alternative Names: | SUM-102PT |
| LINCS ID: | |
| Alternative ID: | |
| Parent Cell Line: | |
| Reference Source: | Asterand SUM-102PT |
| Organism: | Homo sapiens |
| Organ: | breast |
| Tissue: | |
| Cell Type: | |
| Details of Cell Type: | |
| Donor Sex: | |
| Donor Age: | |
| Donor Ethnicity: | |
| Donor Health Status: | |
| Disease: | DOID:3005, invasive ductal carcinoma |
| Details of Disease: | breast ductal adenocarcinoma |
| Production Details: | From Asterand: developed from a patient with minimally invasive, ER negative and PR negative human breast carcinoma. |
| Genetic Modification(s): | none |
| Known Mutations: | |
| Citation Information for Mutations: | |
| Verification Reference Profile: | |
| Growth Properties: | adherent |
| Recommended Culture Conditions: | From Asterand: Ham’s F-12 + 1 g/L bovine serum albumin (fatty acid-free), 10 ng/mL EGF, 5 mM ethanolamine, 10 mM HEPES, 1 ug/mL hydrocortisone, 5 ug/mL insulin, 50 nM sodium selenite, 5 ug/mL apo-transferrin, 10 nM triiodo-L-thyronine |
| Relevant Citations: | PMID 10604729 |
| Usage Note: | |
| Comments: | |
| Date Publicly Available: | 2016-08-24 |
| Most Recent Update: | 2016-08-24 |
Datasets:
| HMS Dataset ID | Dataset Title | HMS Dataset Type |
|---|---|---|
| 20268 | Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. | Analysis |
| 20269 | Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. | Analysis |
Batch Information:
| HMS LINCS Batch ID | Provider | Provider Catalog ID | Provider Batch ID |
|---|---|---|---|
| 51120-1 | Stephen Ethier (Wayne State University and University of Michigan Medical School) |